NVCT Nuvectis Pharma, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Nuvectis Pharma (NVCT) Stock: Buy, Sell, or Hold?

$21.00
-0.08 (-0.38%) ▼
5d: +13.7% 30d: +15.7% 90d: +9.2%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
48/100
Position
EXTENDED
30-Day Fair Range
$18.45 – $20.73
Position: EXTENDED
Forward P/E & Valuation
-13.8x
Next 12M consensus est.
Wall Street Target
$35.40
+68.6% upside
Options IV & Volume
4th pct IV
HIGH volume confirmation
Support / Resistance
$17.10 / $22.18
Trend: Sideways
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: NVCT shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When NVCT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: NVCT is currently trading at $21.00, which is considered extended relative to its 30-day fair value range of $18.45 to $20.73.

Technical Outlook: Technically, NVCT is showing sideways momentum. Immediate support is located at $17.10, while resistance sits at $22.18.

Market Sentiment: NVCT scores 35/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (4th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $35.40 (+68.6%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $18.45 - $20.73
Company Quality Score 48/100 (HOLD)
Options IV Signal 4th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 41.7%

Trading Range & Key Levels

30-Day Trading Range $18.45 - $20.73
Current vs Trading Range EXTENDED
Expected Move (7 Days) ±$2.84 (13.5%)
Support Level $17.10
Resistance Level $22.18
Current Trend Sideways
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BEARISH: Price extended above range
  • BULLISH: Options cheap (IV 4th percentile)
  • BEARISH: Weak technical setup (35/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 68.6% below Wall St target ($35.40)
  • WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -13.83
Wall Street Target $35.40 (+68.6%)
Share NVCT Analysis

Share this live NVCT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (NVCT)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 30, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment dominates $NVCT on StockTwits with no new news articles available.
Key Retail Themes: Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:31 AM ET
Data refreshes hourly during market hours. Next update: 4:31 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for NVCT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 49 HOLD
WVE
Wave Life Sciences Ltd
STRONG BUY
21 analysts
$17 34 SELL
SRRK
Scholar Rock Holding Corp
STRONG BUY
18 analysts
$70 32 SELL
NRIX
Nurix Therapeutics Inc
STRONG BUY
14 analysts
$34 52 HOLD
PALI
Palisade Bio Inc
STRONG BUY
10 analysts
$10 62 BUY

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive NVCT Research Pages
NVCT Technical Chart NVCT Price Prediction NVCT Intrinsic Value DCF NVCT Earnings Date NVCT Investment Advisor NVCT Fair Price Analyzer NVCT Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals